MDT vs. BMY
Compare and contrast key facts about Medtronic plc (MDT) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MDT or BMY.
Correlation
The correlation between MDT and BMY is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MDT vs. BMY - Performance Comparison
Key characteristics
MDT:
0.58
BMY:
0.85
MDT:
0.95
BMY:
1.49
MDT:
1.12
BMY:
1.18
MDT:
0.29
BMY:
0.51
MDT:
1.73
BMY:
2.12
MDT:
6.28%
BMY:
11.50%
MDT:
18.65%
BMY:
28.86%
MDT:
-57.63%
BMY:
-70.62%
MDT:
-24.16%
BMY:
-20.33%
Fundamentals
MDT:
$118.56B
BMY:
$122.91B
MDT:
$3.27
BMY:
-$3.58
MDT:
1.54
BMY:
2.07
MDT:
$33.00B
BMY:
$35.96B
MDT:
$20.67B
BMY:
$24.67B
MDT:
$9.19B
BMY:
$605.00M
Returns By Period
In the year-to-date period, MDT achieves a 15.15% return, which is significantly higher than BMY's 5.04% return. Over the past 10 years, MDT has outperformed BMY with an annualized return of 5.15%, while BMY has yielded a comparatively lower 2.96% annualized return.
MDT
15.15%
13.92%
15.71%
8.78%
-2.15%
5.15%
BMY
5.04%
3.00%
22.47%
23.71%
1.99%
2.96%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MDT vs. BMY — Risk-Adjusted Performance Rank
MDT
BMY
MDT vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Medtronic plc (MDT) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MDT vs. BMY - Dividend Comparison
MDT's dividend yield for the trailing twelve months is around 3.03%, less than BMY's 4.12% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDT Medtronic plc | 3.03% | 3.49% | 3.34% | 3.44% | 2.39% | 1.95% | 1.87% | 2.15% | 2.24% | 2.34% | 1.88% | 1.66% |
BMY Bristol-Myers Squibb Company | 4.12% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
MDT vs. BMY - Drawdown Comparison
The maximum MDT drawdown since its inception was -57.63%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for MDT and BMY. For additional features, visit the drawdowns tool.
Volatility
MDT vs. BMY - Volatility Comparison
Medtronic plc (MDT) has a higher volatility of 7.26% compared to Bristol-Myers Squibb Company (BMY) at 6.69%. This indicates that MDT's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MDT vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Medtronic plc and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities